SCHEMBL181900

SCHEMBL181900

CC1COc2cn(C)cc2O1

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 2/20 0.30
CHRNA3 P32297 2/20 0.30
CHRNB2 P17787 1/20 0.30
CHRNA4 P43681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3213031 0.75
SCHEMBL3249818 0.75 EBP (0.39)
SCHEMBL759276 0.73
SCHEMBL181760 0.72 BRD4 (0.31)
SCHEMBL3263298 0.72 KMT2A (0.32)
SCHEMBL182227 0.71 ITGB2 (0.43)
SCHEMBL266615 0.70 NISCH (0.48) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL12401665 0.70 NISCH (0.48) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL8347684 0.70 NISCH (0.48) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL3470534 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979916-B1 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS UNIV FLORIDA (US) 2012-03-21 EP claimed
US-7807758-B2 Chemical defunctionalization of polymeric alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-10-05 US claimed
US-20090221763-A1 Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2009-09-03 US claimed
EP-1979916-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS University of Florida Research Foundation, Incorporated (US) 2008-10-15 EP claimed
WO-2007087587-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2007-08-02 WO claimed
EP-2402955-B1 Chemical defunctionalization of polymeric alkylenedioxyheterocyclics - the monomers UNIV FLORIDA (US) 2013-07-03 EP disclosed
EP-1979916-B1 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS UNIV FLORIDA (US) 2012-03-21 EP disclosed
EP-2402955-A1 Chemical defunctionalization of polymeric alkylenedioxyheterocyclics - the monomers University of Florida Research Foundation, Incorporated (US) 2012-01-04 EP disclosed
US-7807758-B2 Chemical defunctionalization of polymeric alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-10-05 US disclosed
US-20090221763-A1 Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2009-09-03 US disclosed
EP-1979916-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS University of Florida Research Foundation, Incorporated (US) 2008-10-15 EP disclosed
WO-2007087587-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221763-A1 Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics DDT, STAT3, PTPN22 CHRNB4 3665/4885CHRNA3 2826/4885CHRNB2 3064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.